ULBP1 is a prognostic biomarker associated with immune suppression in breast cancer.

Mao Q, Zheng Y, Liu S, Li Y, Shen Y, Zhuang H.

Open source

DOI: 10.3389/fonc.2026.1788245
Published: 2026-08-26
Container: Front Oncol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1788245,
  title = {ULBP1 is a prognostic biomarker associated with immune suppression in breast cancer.},
  author = {Mao Q and  Zheng Y and  Liu S and  Li Y and  Shen Y and  Zhuang H.},
  year = {2026},
  journal = {Front Oncol},
  doi = {10.3389/fonc.2026.1788245},
  url = {https://doi.org/10.3389/fonc.2026.1788245}
}

RIS

TY  - JOUR
TI  - ULBP1 is a prognostic biomarker associated with immune suppression in breast cancer.
AU  - Mao Q
AU  -  Zheng Y
AU  -  Liu S
AU  -  Li Y
AU  -  Shen Y
AU  -  Zhuang H.
PY  - 2026
JO  - Front Oncol
DO  - 10.3389/fonc.2026.1788245
UR  - https://doi.org/10.3389/fonc.2026.1788245
ER  -

APA

Q, M., Y, Z., S, L., Y, L., Y, S., & H., Z. (2026). ULBP1 is a prognostic biomarker associated with immune suppression in breast cancer.. Front Oncol. https://doi.org/10.3389/fonc.2026.1788245

Source records

europe-pmc · retrieved 2026-09-25T20:54:27.242Z
doaj · retrieved 2026-09-25T20:54:27.240Z